Anne Marie Rasmussen

Summary

Affiliation: Institute for Cancer Research
Country: Norway

Publications

  1. doi request reprint Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy
    Anne Marie Rasmussen
    Department of Immunology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    J Immunol Methods 355:52-60. 2010
  2. doi request reprint Transiently redirected T cells for adoptive transfer
    Hilde Almåsbak
    Section for Immunology, Radiumhospitalet, Oslo University Hospital, Oslo, Norway
    Cytotherapy 13:629-40. 2011
  3. pmc Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
    Einar Osland Vik-Mo
    Vilhelm Magnus Laboratory for Neurosurgical Research, Institute for Surgical Research, University of Oslo, Oslo, Norway
    Cancer Immunol Immunother 62:1499-509. 2013
  4. doi request reprint Non-MHC-dependent redirected T cells against tumor cells
    Hilde Almåsbak
    Department of Immunology, Radiumhospitalet Rikshospitalet, University Hospital, Oslo, Norway
    Methods Mol Biol 629:453-93. 2010
  5. pmc hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
    Else M Inderberg Suso
    Section for Immunology, Oslo University Hospital and University of Oslo, Radiumhospitalet, Montebello, 0310, Oslo, Norway
    Cancer Immunol Immunother 60:809-18. 2011

Collaborators

  • Gustav Gaudernack
  • Hilde Almåsbak
  • Eirik Helseth
  • Einar Osland Vik-Mo
  • Steinar Aamdal
  • Gunnar Kvalheim
  • Else M Inderberg Suso
  • Jan E Brinchmann
  • Knut Lote
  • Iver A Langmoen
  • Birthe Viftrup Mikkelsen
  • Stein Sæbøe-Larssen
  • Cecilie Sandberg
  • Morten Carstens Moe
  • Else Marit Inderberg Suso
  • Paulina Due-Tønnesen
  • Marta Nyakas
  • Turid Vetrhus
  • Svein Dueland

Detail Information

Publications5

  1. doi request reprint Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy
    Anne Marie Rasmussen
    Department of Immunology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    J Immunol Methods 355:52-60. 2010
    ..Based on these data we have developed a cGMP protocol for expansion of tumor specific T cells for adoptive T cell therapy...
  2. doi request reprint Transiently redirected T cells for adoptive transfer
    Hilde Almåsbak
    Section for Immunology, Radiumhospitalet, Oslo University Hospital, Oslo, Norway
    Cytotherapy 13:629-40. 2011
    ..We demonstrate that transfection of T cells with messenger (m) RNA coding for CAR is an alternative strategy...
  3. pmc Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
    Einar Osland Vik-Mo
    Vilhelm Magnus Laboratory for Neurosurgical Research, Institute for Surgical Research, University of Oslo, Oslo, Norway
    Cancer Immunol Immunother 62:1499-509. 2013
    ..Although experimental data have suggested the importance of CSCs, few data exist regarding the potential relevance and importance of these cells in a clinical setting...
  4. doi request reprint Non-MHC-dependent redirected T cells against tumor cells
    Hilde Almåsbak
    Department of Immunology, Radiumhospitalet Rikshospitalet, University Hospital, Oslo, Norway
    Methods Mol Biol 629:453-93. 2010
    ..We are currently scaling up the protocols to adapt them to cGMP production of a large number of redirected T cells for clinical applications...
  5. pmc hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
    Else M Inderberg Suso
    Section for Immunology, Oslo University Hospital and University of Oslo, Radiumhospitalet, Montebello, 0310, Oslo, Norway
    Cancer Immunol Immunother 60:809-18. 2011
    ..A thorough analysis of this patient immune response has provided a unique opportunity to identify novel epitopes, associated with clinical effects. These will be included in future hTERT vaccines...